Purchases and Sales Made in Q3 2022 in Acasti Pharma Inc. (ACST)
This table provides information about the institutional ownership of Acasti Pharma Inc. (ACST) during Q3 2022. The information is specifically focused on institutions that hold shares of Acasti Pharma Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
24.3KNew |
$15.1K - $88.9K
|
24.3K
$78.7K
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
17.8KNew |
$11.1K - $65.2K
|
17.8K
$57.8K
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
706+ 178.73% |
$438 - $2.58K
|
1.1K
$3.57K
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 14, 2024
Q3 2022
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
SELL
|
- |
-45- 19.57% |
$27.9 - $165
|
185
$599
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-7.37K- 39.48% |
$4.57K - $27K
|
11.3K
$36.6K
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Securities, LLC
New York, NY |
SELL
|
- |
-8.56K- 33.57% |
$5.31K - $31.3K
|
16.9K
$54.9K
|
|
Oct 13, 2022
Q3 2022
|
National Bank Of Canada
|
SELL
|
- |
-15.1K- 82.1% |
$9.38K - $55.3K
|
3.3K
$10.7K
|